10 hrs ago
Johnson & Johnson to seek buyer for medical device maker unit -WSJ
Johnson & Johnson plans to seek a buyer for its medical device maker business, Cordis Corp, The Wall Street Journal reported citing people familiar with the matter.
14 hrs ago
Salt Lake Tribune
IBM's Watson goes from Jeopardy! to J&J scientist
New York a IBM wants you to know that its Watson technology can do more than win "Jeopardy!": It can now help accelerate scientific research and discoveries.
Tue Aug 26, 2014
ViaCyte, Inc. Announces Signing of Rights Agreement with Janssen Research & Development LLC.
ViaCyte, Inc., a privately held regenerative medicine company announced that it has entered into a Rights Agreement with Janssen Research & Development LLC , one of the Janssen Pharmaceutical Companies of Johnson & Johnson.
Mon Aug 25, 2014
Here's Why Johnson & Johnson Is a Good Investment at 52-Week Highs
Johnson & Johnson is appreciating a decent time in 2014, liking 10% and beating the more extensive market so far.
Mon Aug 18, 2014
The Motley Fool
3 Reasons Johnson & Johnson Stock Could Rise
For the quarter, Johnson & Johnson delivered impressive revenue growth of 9.1% year-over-year.
Wed Aug 13, 2014
Check Your Mental Health With Just A Press Of A Button
Philadelphia residents can now check their mental health in the grocery store, thanks to an interactive screening kiosk known as "Checkup and Checkout" that officials unveiled earlier this month.
Fri Aug 08, 2014
Hysterectomy tool creates cancer fears
About 600,000 hysterectomies are performed in the U.S. each year. Research suggests about 40% are done to remove presumably benign or noncancerous fibroids that are causing heavy bleeding, pelvic pressure or pain or other symptoms Power morcellators, like the one below, are used in this procedure, are under scrutiny.
Mon Aug 04, 2014
Outpatient Surgery Magazine
Johnson & Johnson Asks Customers to Return Morcellators
As the polarized debate regarding the safety and desirability of power morcellation in minimally invasive hysterectomies continues to rage, Johnson & Johnson, easily the largest manufacturer of laparoscopic morcellators, has announced that it's withdrawing the device from the market.
Ken Fisher's Top Stock Picks
Fisher's 13F portfolio contains over 600 long equity positions, out of which 81 are new positions, and 262 positions have been increased during the quarter.
Sun Aug 03, 2014
Klobuchar looks into contact lens prices
U.S. Sen. Amy Klobuchar is seeking greater scrutiny of a decision by three of the four top U.S. contact lens makers to set price minimums for products.
Thu Jul 31, 2014
Wall Street Journal
Johnson & Johnson Partners with CircleUp for Early Look at Startups
CircleUp COO Rory Eakin and CEO Ryan Caldbeck with an array of products made by companies that raised equity funding on their site.
Press Digest - Wall Street Journal - July 31
The following are the top stories in the Wall Street Journal. Reuters has not verified these stories and does not vouch for their accuracy.
Wed Jul 30, 2014
Hologic's (HOLX) CEO Stephen MacMillan on Q3 2014 Results - Earnings Call Transcript
Good afternoon, everyone, and welcome to the Hologic, Inc. Third Quarter Fiscal 2014 Earnings Call.
J&J to call for voluntary return of morcellators
Johnson & Johnson, which already suspended sales of a surgical tool that has been blamed for spreading a dangerous cancer in women, now plans to tell doctors world-wide to return any devices currently on shelves.